Delivery Order SPE2DB24D9245-SPE2DB25FHMHT
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order covers the supply of Stelara 90 mg/ml syringes, a biologic medication used to treat autoimmune conditions, with an ultimate completion date of September 22, 2025. This award was issued without a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Stelara 90 mg/mL syringes. The award represents a firm fixed-price delivery order with no set-aside designation, utilizing the company's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The product will be delivered to Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 19, 2025. The delivery order covers Stelara 90 mg/mL syringes, a biologic medication used primarily for autoimmune conditions. This award was issued without a set-aside designation, allowing the company to compete on its merits within the broader federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on July 18, 2025. The delivery order, which must be completed by August 8, 2025, is for Stelara 90 mg/mL syringes and was issued without a set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for Stelara 90 mg/mL syringes valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 15, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 8, 2025, represents a standard procurement action with no set-aside designation. The contract will be performed at the awardee's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for Stelara 90 mg/ml syringes with a ceiling value of $64,999.80. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and effective through November 2026. The award carries...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/mL syringes. This firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency (DLA) on July 31, 2025. The delivery order, with an ultimate completion date of August 21, 2025, covers the supply of Stelara 90 mg/ml syringes—a prescription biologic medication used primarily for treating inflammatory conditions. This award carries no set-aside designation,...
- SPE2DB24D9245Indefinite Delivery Contract
- SPE2DB24D9245-SPE2DB25FHMHTDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 9, 2025. The delivery order is for Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award was issued without a set-aside designation and carries an ultimate completion date of September 30, 2025, with performance to be fulfilled at the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The IDC, established under the DLA's SPE2DB program, authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting medical supply needs of military healthcare facilities. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/9/25 |